MabVax Therapeutics Presents Two Posters At The AACR Annual Meeting On A Novel Radioimmunotherapy Treatment For Pancreatic Cancer Post author:Sam Post published:April 4, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Telix Pharma, Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer January 18, 2017 NeoTract, Inc.'s Minimally Invasive UroLift System For Enlarged Prostate Now Shown To Be Durable Through Five Years: Results From Pivotal L.I.F.T. Randomized Study Presented March 26, 2017 Antibe Therapeutics Announces Closing Of Public Offering June 20, 2017
Telix Pharma, Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer January 18, 2017
NeoTract, Inc.'s Minimally Invasive UroLift System For Enlarged Prostate Now Shown To Be Durable Through Five Years: Results From Pivotal L.I.F.T. Randomized Study Presented March 26, 2017